miR-361-5p等miRNA对鸟分枝杆菌复合群疾病的早期诊断和在感染中的作用机制研究
批准号:
81902109
项目类别:
青年科学基金项目
资助金额:
21.0 万元
负责人:
潘新灵
依托单位:
学科分类:
病原生物与感染研究新技术与新方法
结题年份:
2022
批准年份:
2019
项目状态:
已结题
项目参与者:
中文摘要
鸟分枝杆菌复合群(Mycobacterium avium complex, MAC)在非结核分枝杆菌中占重要地位,引起的MAC疾病的临床表现与结核分枝杆菌复合群感染类似,实现MAC疾病的早期诊断和精准分型有助于MAC肺病的合理治疗,也有利于耐药肺结核的治疗和控制。现有诊断方法不能满足MAC疾病早期精确诊断的目的。因此,本研究拟采用全基因组测序对MAC进行分子分型,并建立MAC疾病的精准分型;建立RT-qPCR法在临床样本中验证及前瞻性评估前期研究中筛选到的MAC感染相关miRNA,明确miRNA对MAC疾病和不同型别MAC疾病的诊断能力;此外,运用细胞感染模型,探究具有诊断意义的miRNA(如miR-361-5p)在MAC感染中的作用及机制,明确其靶向调控的信号通路,不仅为miRNA作为MAC疾病的标志物提供理论基础,也为MAC疾病的预防和治疗提供科学依据。
英文摘要
Mycobacterium avium complex (MAC) was the most important pathogen in non-tuberculous mycobacteria, caused infections which shared common clinical features with diseases caused by mycobacterium tuberculosis complex. Therefore, early diagnosis and accurate typing of MAC diseases were significant not only for the therapy of MAC diseases, buy also the control of drug resistant-tuberculosis. However, the examination methods used currently could not distinguish MAC diseases from other mycobacterial infections in the early phase of diagnosis. Therefore, the MAC diseases were typed based on the genotypes of MAC strains generated by whole genome sequencing. The associations between the genotypes of strains and clinical features of MAC diseases were established. Then, the candidate serum miRNAs (e. g: miR-361-5p), which showed a potential significance in diagnosis of MAC diseases, were validated by RT-qPCR in this study and further were used to relate with the types of MAC diseases. At last, the functions of miR-361-5p were explored in the MAC infection model, to investigate how it regulated the lives of intracellular MAC. This study would contribute to the accurate diagnosis of MAC disease and clarify the mechanism of how the miRNAs functioned in MAC infection, providing new potential targets for immunotherapy for MAC disease in the future.
背景:鸟胞分枝杆菌复合群菌株(Mycobacterium avium complex, MAC)引起的肺部感染与结核分枝杆菌(Mycobacterium tuberculosis complex, MTBC)肺病在临床表现、实验室检查和影像学存在相似之处,现有的诊断依赖于传统的细菌培养和分子检测技术,难以实现早期的筛查和诊断。近年来,结核病患者外周血中的miRNA具有诊断价值,为MAC病的诊断提供依据。.结果:本地区在2016年1月至2022年12月间共有1064株mpt64抗原阴性菌株,经hsp65鉴定的有638株,其中59株为结核分枝杆菌。本地区的MAC菌株占非结核分枝杆菌中的82.0%(465/567),其中的菌种包括嵌合分枝杆菌(52.0%)、胞内分枝杆菌(24%)和哥伦比亚分枝杆菌(16%)。本地区MAC菌株的利奈唑胺耐药率高达98.0%,克拉霉素的耐药率为4%,耐药MIC值分布与MAC分离频次无关,但低MIC值与胞内分枝杆菌和哥伦比亚分枝杆菌有关。相对于单次MAC分离阳性的患者,多次MAC菌株分离阳性的患者有更高的抗酸阳性率和慢性阻塞性肺病共患病率,但T.spot阳性率更低;分离出哥伦比亚菌株的患者在培养前的抗酸涂片阳性率远低于胞内分枝杆菌和嵌合分枝杆菌。PC-3p-18531_108和hsa-miR-361-5p分别在健康者和MTBC感染者血清、MAC感染者和健康对照组间存在表达差异,但无区分能力。哥伦比亚感染者血清中的PC-3p-13226_160和miR-412-5p表达水平显著低于嵌合分枝杆菌和胞内分枝杆菌感染患者。.科学意义:MAC的菌种分布和耐药水平可以为临床上的治疗提供参考依据,血清中差异的miRNA为MAC病和MTBC病的鉴别诊断提供潜在可能,但仍需进行进一步的探索和验证。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Molecular identification and clinical significance of Mycobacterium seoulense strains from patients with nontuberculous mycobacterium infections
非结核分枝杆菌感染患者首尔分枝杆菌菌株的分子鉴定及临床意义
DOI:
10.1016/j.diagmicrobio.2022.115756
发表时间:
2022
期刊:
Diagn Microbiol Infect Dis
影响因子:
--
作者:
[Jin Zhao, Bin Lu, Yangxiao Zhou, Sipei Wang, Xinling Pan]
通讯作者:
Xinling Pan
国内基金
海外基金